RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.
暂无分享,去创建一个
Patricia J Keely | Channing J Der | C. Der | P. Keely | Whitney S. Helms | L. Su | Lishan Su | Patricia A Solski | Whitney Helms | P. A. Solski
[1] H. Mellor,et al. The novel Rho-family GTPase Rif regulates coordinated actin-based membrane rearrangements , 2000, Current Biology.
[2] C. Myung,et al. Role of Isoprenoid Lipids on the Heterotrimeric G Protein γ Subunit in Determining Effector Activation* , 1999, The Journal of Biological Chemistry.
[3] Y. Fukada,et al. Specific isoprenyl group linked to transducin gamma-subunit is a determinant of its unique signaling properties among G-proteins. , 1998, Biochemistry.
[4] P. Casey,et al. Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.
[5] S. Sebti,et al. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts , 1998, Oncogene.
[6] M. Emerman,et al. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.
[7] C. Der,et al. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K , 1997, Nature.
[8] C J Marshall,et al. Post-translational modifications of p21rho proteins. , 1992, The Journal of biological chemistry.
[9] P. Adamson,et al. Intracellular localization of the P21rho proteins , 1992, The Journal of cell biology.
[10] S. Sebti,et al. Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice* , 2000, The Journal of Biological Chemistry.
[11] P. Casey,et al. Farnesyltransferase Inhibitors Alter the Prenylation and Growth-stimulating Function of RhoB* , 1997, The Journal of Biological Chemistry.
[12] G. Prendergast,et al. Critical role of Rho in cell transformation by oncogenic Ras. , 1995, Oncogene.
[13] P. Crespo,et al. The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.
[14] C. Albanese,et al. Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.
[15] C. Der,et al. Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes (*) , 1995, The Journal of Biological Chemistry.
[16] G. Favre,et al. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Sakai,et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. , 1993, Oncogene.
[18] S. Sebti,et al. The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G0/G1 and Induces p21WAF1/CIP1/SDI1 in a p53-independent Manner* , 1997, The Journal of Biological Chemistry.
[19] C. Der,et al. Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF , 1999, Current Biology.
[20] G. Prendergast,et al. Prenylation of RhoB Is Required for Its Cell Transforming Function but Not Its Ability to Activate Serum Response Element-dependent Transcription* , 1997, The Journal of Biological Chemistry.
[21] J. Gibbs,et al. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. , 1997, Annual review of pharmacology and toxicology.
[22] C. Der,et al. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? , 1997, Biochimica et biophysica acta.
[23] J. Settleman,et al. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation , 1996, Molecular and cellular biology.
[24] F. McCormick,et al. An essential role for Rac in Ras transformation , 1995, Nature.
[25] D. Noh,et al. Molecular cloning and sequencing of rat Cdc42 GTPase cDNA , 2000, Experimental & Molecular Medicine.
[26] C. Der,et al. Farnesyltransferase and Geranylgeranyltransferase Inhibitors , 2000 .
[27] C. Der,et al. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein , 1992, Molecular and cellular biology.
[28] V. Ferrans,et al. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation , 1996, Molecular and cellular biology.
[29] C. Der,et al. Modulation of HIV-1 Replication by a Novel RhoA Effector Activity1 , 2000, The Journal of Immunology.
[30] S. Sebti,et al. Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. , 1997, Pharmacology & therapeutics.
[31] S. Merajver,et al. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. , 2000, Cancer research.
[32] S. Sebti,et al. GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. , 1997, Cancer research.
[33] G. Prendergast,et al. Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB , 1999, Molecular and Cellular Biology.
[34] C. Der,et al. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.
[35] C J Marshall,et al. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. , 1991, The EMBO journal.
[36] C. Der,et al. Analyses of transforming activity of Rho family activators. , 2000, Methods in enzymology.
[37] A. Hall,et al. Rho GTPases and their effector proteins. , 2000, The Biochemical journal.
[38] P. Scambler,et al. RhoE Regulates Actin Cytoskeleton Organization and Cell Migration , 1998, Molecular and Cellular Biology.
[39] C. Hauser,et al. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. , 1994, Oncogene.
[40] P. Adamson,et al. Intracellular Localization of the P 2 lrh ~ Proteins , 1992 .
[41] T. Jessell,et al. RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors , 2000, Molecular and Cellular Biology.
[42] John G. Collard,et al. A role for Rac in Tiaml-induced membrane ruffling and invasion , 1995, Nature.
[43] Channing J Der,et al. Rho family proteins and Ras transformation: the RHOad less traveled gets congested , 1998, Oncogene.
[44] David Michaelson,et al. Differential Localization of Rho Gtpases in Live Cells , 2001, The Journal of cell biology.
[45] M. Mattei,et al. A New Member of the Rho Family, Rnd1, Promotes Disassembly of Actin Filament Structures and Loss of Cell Adhesion , 1998, The Journal of cell biology.
[46] S. Sebti,et al. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. , 1996, Oncogene.
[47] R. Bravo,et al. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. , 1997, Genes & development.
[48] P. Fort,et al. Characterization of TCL, a New GTPase of the Rho Family related to TC10 and Cdc42* 210 , 2000, The Journal of Biological Chemistry.
[49] P. Casey,et al. Lipid modifications of G proteins. , 1994, Current opinion in cell biology.
[50] C. Cepko,et al. Construction and applications of a highly transmissible murine retrovirus shuttle vector , 1984, Cell.
[51] S. Sebti,et al. RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription* , 2000, The Journal of Biological Chemistry.
[52] C. Der,et al. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways , 1997, Molecular and cellular biology.
[53] L. Van Aelst,et al. Rho GTPases and signaling networks. , 1997, Genes & development.
[54] R. Treisman,et al. The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.
[55] M. Karin,et al. Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.
[56] P. Keely. Ras and Rho protein induction of motility and invasion in T47D breast adenocarcinoma cells. , 2001, Methods in enzymology.
[57] G. Prendergast,et al. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity , 1995, Molecular and cellular biology.
[58] A. Ashworth,et al. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 , 1995, Science.
[59] P. Casey,et al. Protein Prenyltransferases (*) , 1996, The Journal of Biological Chemistry.
[60] F. McCormick,et al. A role for Rho in Ras transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[61] C. Der,et al. Protein prenylation: more than just glue? , 1992, Current opinion in cell biology.
[62] N. Landau,et al. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor , 1995, Journal of virology.